# Ranolazine

NDC: 60290-056
Generic name: Ranolazine
Labeler / Manufacturer: Umedica Laboratories USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20260810

FDA application: ANDA214551

## Active ingredients

- RANOLAZINE: 1000 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60290-056"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60290-056
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a624dc7f-921d-4554-a813-f72dca0133c3